Rampart Bioscience
La Jolla
About Rampart Bioscience
Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from a variety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $85.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: rampartbio.com
Industries & Categories
Biopharma, Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rampart-bioscience-82301 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.